Yesafili is indicated for the treatment of: Neovascular (wet) age-related macular degeneration (wet AMD).
Visual impairment due to macular oedema secondary to retinal vein occlusion (branch RVO or central RVO).
Visual impairment due to diabetic macular oedema (DME).
Visual impairment due to myopic choroidal neovascularisation (myopic CNV).
Sign Out